Brian Kidd Sells Shares of National HealthCare Corporation
National HealthCare's SVP and CFO, Brian Kidd, sold 500 shares on June 16, 2026.
Key Points
- Brian Kidd, SVP and CFO of National HealthCare Corporation, sold 500 shares on June 16, 2026, with the stock trading at $201.53.
- National HealthCare Corporation, trading on the NYSE American under the ticker NHC, has a market cap of approximately $3.15 billion and a P/E ratio of 25.6.
- Institutional investors like BlackRock and Dimensional Fund Advisors have adjusted their positions in National HealthCare Corporation recently.
On June 16, 2026, Brian Kidd, the Senior Vice President and Chief Financial Officer of National HealthCare Corporation (NYSE American: NHC), sold 500 shares of the company. The transaction occurred with the stock trading at approximately $201.53 per share. This sale was not part of a pre-planned trading program.
Insider Buying and Selling at National HealthCare Corporation
Apart from Brian Kidd's transaction, other insiders have also been active. On the same day, Emil Hassan sold 1,563 shares at an average price of $199.98. Earlier in June, Robert Adams bought 4,000 shares at $69.19 and sold 4,000 shares at a price of $0.00 in separate transactions. Additionally, Lisa Piercey acquired 949 shares at $184.26 on June 1, 2026.
Other Institutional Activity in National HealthCare Corporation
In recent institutional activity, BlackRock, Inc. reduced its holdings in National HealthCare Corporation by 6,847 shares, ending with 1,895,250 shares valued at about $302.67 million. Dimensional Fund Advisors LP also trimmed its position by 11,301 shares, leaving it with 946,977 shares worth approximately $151.24 million. On the other hand, First Trust Advisors LP increased its stake by 165,615 shares, bringing its total to 530,302 shares valued at around $84.69 million.
National HealthCare Corporation Stock Snapshot
Shares of National HealthCare Corporation traded near $201.53 on the NYSE American. The company boasts a market cap of approximately $3.15 billion and a P/E ratio of 25.6. The stock has seen a 52-week low of $93.54 and a high of $205.90. Its 50-day moving average is $182.61, while the 200-day moving average is $149.73. The company has a beta of 0.666, indicating lower volatility compared to the market.
Recent Earnings
National HealthCare Corporation reported revenues of about $1.53 billion, reflecting a growth of 2.2%. The company achieved a net margin of 8.1% and a return on equity (ROE) of 12.0%. Earnings per share (EPS) stood at $7.87. The next earnings report is scheduled for August 6, 2026.
Dividend
The company offers an annual dividend rate of $2.59, yielding 1.35%. Its dividend payout ratio is approximately 32.5%.
About National HealthCare Corporation
National HealthCare Corporation, headquartered in Murfreesboro, Tennessee, operates skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. The company is divided into two segments: Inpatient and Homecare and Hospice Services. It provides a range of services including licensed therapy, nutrition, social services, and housekeeping. Under the leadership of CEO Dr. Stephen Fowler Flatt, the company employs about 15,278 people.
Bottom Line
Brian Kidd's recent sale of shares is part of a broader trend of insider transactions at National HealthCare Corporation. Investors keep an eye on such moves as they might provide insights into the company's future prospects. While insider sales can be routine, they are closely monitored by market participants for any potential signals. As always, it's essential to remember that 13F filings and insider transactions are backward-looking and may not reflect the current position or sentiment of the insiders.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.